A bill for an act relating to the medical use of cannabidiol including the rescheduling of a cannabidiol investigational product approved as a prescription drug medication under federal law and including effective date provisions. (See SF 470.)
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2017
Committee Review
Floor Vote
Governor
Introduced Feb 16, 2017
Last action Mar 2, 2017
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
5
Key actions
0
Committee
4
Mar 2, 2017
Legislature · Reported by committee
Subcommittee recommends passage.
Feb 28, 2017
Senate · Reported by committee
Subcommittee: Greene, Bolkcom, and Shipley.
Feb 27, 2017
Senate · Referred to committee
Referred to Human Resources.
Feb 22, 2017
Senate · Reported by committee
Subcommittee: Zaun, Bisignano, and Shipley.
Feb 16, 2017
Senate · Introduced
Introduced, referred to Judiciary.
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Brad Zaun
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about SF 282
Scope: IA
Hi! I can help you understand SF 282. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline